NCT02928172

Brief Summary

Hypothesis: There is a statistically measurable correlation between qNOX and rough clinical signs of insufficient anti-nociception such as movements during Laryngeal Mask Airway (LMA) insertion, skin Incision, LMA removal. It will reduce the problem of anticipating the nociception in patients undergoing general anesthesia. Objectives:

  1. 1.to compare two indexes of hypnosis, the qCON (Quantium Medical, Spain) with the Bispectral index (BIS™) (Covidien, Boulder CO. USA), in patients undergoing surgery under sedation and general anesthesia.
  2. 2.to assess the qNOX index of pain/nociception (Quantium Medical, Barcelona, Spain) and the qCON index of hypnosis.
  3. 3.to assess qNOX reliability as a specific indicator of response to nociceptive stimulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 10, 2016

Completed
1.2 years until next milestone

Study Start

First participant enrolled

January 2, 2018

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2023

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

May 24, 2024

Completed
Last Updated

May 28, 2024

Status Verified

May 1, 2024

Enrollment Period

5.1 years

First QC Date

October 4, 2016

Results QC Date

March 5, 2024

Last Update Submit

May 23, 2024

Conditions

Keywords

q-CONq-NOXBISElectroencephalograms (EEG)Laryngeal Mask Airway (LMA)SedationGeneral Anesthesia

Outcome Measures

Primary Outcomes (2)

  • Movements as Response to Laryngeal Mask Airway (LMA) Insertion

    Correlation between qNOX-qNOX and rough clinical signs of insufficient anti-nociception during Laryngeal Mask Airway (LMA) insertion The Laryngeal Mask Airway (LMA) insertion occurs during the induction, lasting an average of 5-10 minutes. Total number of movements reported for the group as a whole and not per participant.

    Approximately 10 minutes

  • Number Coughing/Bucking

    Coughing/bucking as a response to intraoperative stimuli. The total number of coughing/bucking reported intraoperatively for the group as a whole was recorded. The intraoperative period lasted approximately 30 min to 3 hours.

    Intraoperative period (30 minutes to 3 hours)

Secondary Outcomes (1)

  • Number of Intraoperative Movements

    Intraoperative period (30 minutes to 3 hours)

Study Arms (1)

Depth of Anesthesia

OTHER

Subjects will have the qCON-qNOX and BIS monitor

Device: qCON-qNOXDevice: BIS

Interventions

qCON-qNOXDEVICE

Each subject will have the qCON-qNOX monitor on his/her forehead + the BIS monitor

Depth of Anesthesia
BISDEVICE

Each subject will have the BIS monitor on his/her forehead + the qCON-qNOX monitor

Depth of Anesthesia

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled to undergo general surgical procedures with general anesthesia/LMA.
  • Willingness and ability to sign an informed consent document.
  • years of age.
  • ASA Class I - III adults of either sex

You may not qualify if:

  • Inability to consent
  • Withdrawal criteria
  • Electrodes should be changed when patient's skin impedance value exceeds 15 kΩ after conditioning skin properly. If after two changes of electrodes, impedance remains above 15 kΩ, patient will be excluded from the present study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cedars Sinai Medical Center

Los Angeles, California, 90048, United States

Location

Results Point of Contact

Title
Dr. Ofelia Loani Elvir Lazo, Research Project Advisor
Organization
Cedars Sinai Medical Center

Study Officials

  • Roya Yumul, M.D., PhD

    Cedars-Sinai Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 4, 2016

First Posted

October 10, 2016

Study Start

January 2, 2018

Primary Completion

February 20, 2023

Study Completion

February 20, 2023

Last Updated

May 28, 2024

Results First Posted

May 24, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations